Business Description
BL Pharmtech Corp
ISIN : KR7065170003
Compare
Compare
Traded in other countries / regions
065170.Korea IPO Date
2002-11-19Description
BL Pharmtech Corp is engaged in the distribution and sale of healthy functional foods.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.1 | |||||
| Equity-to-Asset | 0.7 | |||||
| Debt-to-Equity | 0.14 | |||||
| Debt-to-EBITDA | -0.46 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | -1.34 | |||||
| Beneish M-Score | -3.59 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -32.2 | |||||
| 3-Year EBITDA Growth Rate | 0.5 | |||||
| 3-Year EPS without NRI Growth Rate | 6.6 | |||||
| 3-Year Book Growth Rate | -22.5 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 74.31 | |||||
| 9-Day RSI | 66.47 | |||||
| 14-Day RSI | 62.54 | |||||
| 6-1 Month Momentum % | 2.43 | |||||
| 12-1 Month Momentum % | -32.06 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.12 | |||||
| Quick Ratio | 1.89 | |||||
| Cash Ratio | 1.66 | |||||
| Days Inventory | 335.87 | |||||
| Days Sales Outstanding | 128.99 | |||||
| Days Payable | 163.69 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.8 | |||||
| Shareholder Yield % | 29.42 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 55.3 | |||||
| Operating Margin % | -27.7 | |||||
| Net Margin % | -0.61 | |||||
| FCF Margin % | 31.31 | |||||
| ROE % | -0.49 | |||||
| ROA % | -0.17 | |||||
| ROIC % | -7.68 | |||||
| ROC (Joel Greenblatt) % | -32.27 | |||||
| ROCE % | -24.54 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio without NRI | 7.06 | |||||
| Price-to-Owner-Earnings | 1336.09 | |||||
| PS Ratio | 1.81 | |||||
| PB Ratio | 1.41 | |||||
| Price-to-Tangible-Book | 1.44 | |||||
| Price-to-Free-Cash-Flow | 5.8 | |||||
| Price-to-Operating-Cash-Flow | 5.57 | |||||
| EV-to-EBIT | -2.89 | |||||
| EV-to-EBITDA | -3.81 | |||||
| EV-to-Revenue | 1.44 | |||||
| EV-to-FCF | 4.45 | |||||
| Price-to-Median-PS-Value | 1.44 | |||||
| Price-to-Graham-Number | 0.67 | |||||
| Price-to-Net-Current-Asset-Value | 12.59 | |||||
| Earnings Yield (Greenblatt) % | -34.62 | |||||
| FCF Yield % | 17.25 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers